GMAB — Genmab A/S stock price, charts and financials

QT57Genmab A/S

Genmab A/S (NASDAQ: GMAB) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
29.02
+0.34+1.19%
OverviewShort InterestFilings
GMABQT57Genmab A/S·NASDAQ
29.02+1.19%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 15, 20266-KForeign issuer report
Jun 29, 20266-KForeign issuer report
Jun 17, 20266-KForeign issuer report
Jun 16, 20266-KForeign issuer report
Jun 15, 20266-KForeign issuer report
Jun 15, 20266-KForeign issuer report
Jun 11, 20266-KForeign issuer report
May 29, 20266-KForeign issuer report
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 13, 20266-KForeign issuer report
May 12, 20266-KForeign issuer report
May 08, 20266-KForeign issuer report
May 07, 20266-KForeign issuer report
Apr 17, 20266-KForeign issuer report
Apr 17, 20266-KForeign issuer report
Apr 14, 20266-KForeign issuer report
Apr 14, 20266-KForeign issuer report
Apr 01, 20266-KForeign issuer report
Apr 01, 20266-KForeign issuer report
Mar 30, 20266-KForeign issuer report
Mar 23, 20266-KForeign issuer report
Mar 19, 20266-KForeign issuer report
Mar 19, 20266-KForeign issuer report
Mar 16, 20266-KForeign issuer report
Mar 09, 20266-KForeign issuer report
#1 / 25 of 366
Page
▼
/ 15